Alkermes’ Corporate Presentation to be Webcast at the Thomas Weisel Partners Annual Healthcare Conference
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2009 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Wednesday, September 9, 2009, at 1:30 p.m. ET from the Four Seasons Hotel in Boston. The presentation may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
